semustine has been researched along with Cancer of Prostate in 3 studies
Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "9 advanced prostate cancer patients were given a dose of 1-(2-chlorethyl-3[4-methyl cyclohexyl]-1-nitrosourea) (MeCCNU) 175 mg/m2 orally every 6 weeks." | 1.26 | Chemotherapy of advanced, hormonally resistant prostatic carcinoma. ( Catane, R; Madajewicz, S; Mittelman, A; Murphy, GP; Wajsman, Z, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, JD | 2 |
| Loening, SA | 1 |
| Scott, WW | 1 |
| deKernion, J | 1 |
| Gibbons, RP | 1 |
| Johnson, DE | 1 |
| Pontes, JE | 1 |
| Prout, GR | 1 |
| Soloway, MS | 1 |
| Chu, TM | 1 |
| Gaeta, JF | 1 |
| Slack, NH | 1 |
| Murphy, GP | 2 |
| Madajewicz, S | 1 |
| Catane, R | 1 |
| Mittelman, A | 1 |
| Wajsman, Z | 1 |
1 review available for semustine and Cancer of Prostate
| Article | Year |
|---|---|
Cytotoxic agents effective in prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorourac | 1983 |
1 trial available for semustine and Cancer of Prostate
| Article | Year |
|---|---|
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Hu | 1981 |
1 other study available for semustine and Cancer of Prostate
| Article | Year |
|---|---|
Chemotherapy of advanced, hormonally resistant prostatic carcinoma.
Topics: Antineoplastic Agents; Bone Marrow; Cisplatin; Drug Evaluation; Drug Resistance; Drug Therapy, Combi | 1980 |